serine hydrolase modulators (Abide/Celgene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameserine hydrolase modulators (Abide/Celgene)
Drug Alias NameAB-101131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHydrolases modulators
TargetsHydrolases
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbide Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene CorpAbide Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A